Bernstein starts coverage of Amphenol stock at USD 99.00
📈 Amphenol reported second-quarter sales of USD 8.76 billion, representing a robust 55% year-over-year increase.
📊 Orders reached USD 10.732 billion, yielding a strong 1.23 book-to-bill ratio that signals sustained demand.
💰 Adjusted operating margins expanded to 29.80%, up 4.20 percentage points from the previous year.
🚀 Adjusted diluted earnings per share surged 67% to USD 1.35, driven by operational efficiency gains.
📱 Communications Solutions revenue jumped 85% year over year to USD 5.38 billion in the second quarter.
💻 IT datacom segment accounted for 43% of sales with an impressive 89% year-over-year growth rate.
🔮 Third-quarter sales guidance is set between USD 9.3 billion and USD 9.4 billion, maintaining momentum.
📈 Bernstein initiated coverage with an Outperform rating and a price target of USD 99.00.
🤝 CommScope sales outlook was raised to USD 4.6 billion with increased earnings accretion expectations.
📉 MarketBeat notes that while 16 of 18 analysts rate the stock as Buy, valuation concerns exist.
- Amphenol achieved a massive 55% year-over-year sales increase in Q2 2026, reaching USD 8.76 billion.
- The company delivered a 1.23 book-to-bill ratio with orders of USD 10.732 billion, indicating strong pipeline health.
- Adjusted operating margins expanded significantly to 29.80%, reflecting improved operational leverage.
- Adjusted diluted earnings per share grew 67% year over year to USD 1.35.
- Communications Solutions revenue surged 85% to USD 5.38 billion, driven by strong IT datacom demand.
- The IT datacom segment grew organically by 63%, highlighting successful product adoption in high-growth sectors.
- Management raised the full-year CommScope sales outlook to USD 4.6 billion with higher earnings accretion.
- Bernstein initiated coverage with an Outperform rating and a USD 99.00 price target, validating growth potential.
- Strong analyst consensus with 16 out of 18 covering analysts maintaining Buy ratings on the stock.
- MarketBeat identifies valuation concerns as a counterweight to the company's strong growth trajectory.
- Insider selling activity is noted by analysts as a potential negative signal amidst the bullish outlook.